Neon raises $100M in NASDAQ IPO

Neoantigen play Neon Therapeutics Inc. (NASDAQ:NTGN) raised $100 million late Tuesday through the sale of 6.3 million shares at $16, the midpoint of its proposed range of $15-$17. The price values Neon at $451.2 million. Underwriters on the offering are Morgan Stanley, BofA Merrill Lynch, Mizuho and Oppenheimer.

Third Rock Ventures is Neon’s largest shareholder with a 34.5% stake (see “Lighting up Neoantigens”)...